Grislim 250 Tablet contains Griseofulvin 250mg, a systemic antifungal agent used for the effective treatment of dermatophyte infections affecting keratinized tissues such as skin, scalp, hair, and nails. It works by inhibiting fungal mitosis, preventing the growth and spread of infection.
This higher-strength formulation is commonly prescribed in moderate to severe fungal infections including tinea corporis, tinea cruris, tinea capitis, and onychomycosis where prolonged systemic therapy is required. Its deep tissue penetration ensures sustained antifungal activity.
Griseofulvin remains a trusted molecule in dermatology due to its long clinical history and predictable outcomes. The 250mg dosage offers convenience and improved compliance for adult patients requiring effective long-term antifungal management.
Grislim 250 Tablet adds strong value to any dermatology and antifungal therapy segment, ensuring steady demand from dermatologists, hospitals, pharmacies, and export markets. Its established efficacy and wide prescriber acceptance make it a reliable choice for pharmaceutical manufacturing and distribution portfolios.